Top Key Companies for Monkeypox Treatment Market: Bavarian Nordic, Chimerix, Inc., CIDIC Company Limited, Emcure Pharmaceuticals, Emergent, Gilead Sciences Inc., Hetero Drugs Limited, Jinan Jinda Pharmaceutical Chemistry Co. Ltd., Mylan N.V., Olon S.p.A., Piramal Pharma Solutions, SIGA Technologies Inc., Sonofi SA, Teva Pharmaceutical Industries Limited.
Global Monkeypox Treatment Market Size was estimated at USD 324 million in 2022 and is projected to reach USD 295.91 million by 2028, exhibiting a CAGR of -1.5% during the forecast period.
Global Monkeypox Treatment Market Overview And Scope:
The Global Monkeypox Treatment Market Report 2026 provides comprehensive analysis of market development components, patterns, flows, and sizes. This research study of Monkeypox Treatment utilized both primary and secondary data sources to calculate present and past market values to forecast potential market management for the forecast period between 2026 and 2035. It includes the study of a wide range of industry parameters, including government policies, market environments, competitive landscape, historical data, current market trends, technological innovations, upcoming technologies, and technological progress within related industries. Additionally, the report provides an in-depth analysis of the value chain and supply chain to demonstrate how value is added at every stage in the product lifecycle. The study incorporates market dynamics such as drivers, restraints/challenges, trends, and their impact on the market.
This Market Research Report provides a comprehensive analysis of the global Monkeypox Treatment Market and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Monkeypox Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Monkeypox Treatment market.
Global Monkeypox Treatment Market Segmentation
By Type, Monkeypox Treatment market has been segmented into:
Oral
Injectable
By Application, Monkeypox Treatment market has been segmented into:
Hospital Pharmacy
Online Pharmacy
Retail Pharmacy
Regional Analysis of Monkeypox Treatment Market:
North America (U.S., Canada, Mexico)
Eastern Europe (Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe)
Western Europe (Germany, UK, France, Netherlands, Italy, Russia, Spain, Rest of Western Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa)
Competitive Landscape of Monkeypox Treatment Market:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Monkeypox Treatment market study focused on including all the primary level, secondary level and tertiary level competitors in the report.The data generated by conducting the primary and secondary research. The report covers detail analysis of driver, constraints and scope for new players entering the Monkeypox Treatment market.
Top Key Companies Covered in Monkeypox Treatment market are:
Bavarian Nordic
Chimerix
Inc.
CIDIC Company Limited
Emcure Pharmaceuticals
Emergent
Gilead Sciences Inc.
Hetero Drugs Limited
Jinan Jinda Pharmaceutical Chemistry Co. Ltd.
Mylan N.V.
Olon S.p.A.
Piramal Pharma Solutions
SIGA Technologies Inc.
Sonofi SA
Teva Pharmaceutical Industries Limited
Chapter 1: Introduction
1.1 Research Objectives
1.2 Research Methodology
1.3 Research Process
1.4 Scope and Coverage
1.4.1 Market Definition
1.4.2 Key Questions Answered
1.5 Market Segmentation
Chapter 2:Executive Summary
Chapter 3:Growth Opportunities By Segment
3.1 By Type
3.2 By Application
Chapter 4: Market Landscape
4.1 Porter's Five Forces Analysis
4.1.1 Bargaining Power of Supplier
4.1.2 Threat of New Entrants
4.1.3 Threat of Substitutes
4.1.4 Competitive Rivalry
4.1.5 Bargaining Power Among Buyers
4.2 Industry Value Chain Analysis
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.3.3 Opportunities
4.5.4 Challenges
4.4 Pestle Analysis
4.5 Technological Roadmap
4.6 Regulatory Landscape
4.7 SWOT Analysis
4.8 Price Trend Analysis
4.9 Patent Analysis
4.10 Analysis of the Impact of Covid-19
4.10.1 Impact on the Overall Market
4.10.2 Impact on the Supply Chain
4.10.3 Impact on the Key Manufacturers
4.10.4 Impact on the Pricing
Chapter 5: Monkeypox Treatment Market by Type
5.1 Monkeypox Treatment Market Overview Snapshot and Growth Engine
5.2 Monkeypox Treatment Market Overview
5.3 Oral
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size (2026-2035F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Oral: Geographic Segmentation
5.4 Injectable
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size (2026-2035F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Injectable: Geographic Segmentation
Chapter 6: Monkeypox Treatment Market by Application
6.1 Monkeypox Treatment Market Overview Snapshot and Growth Engine
6.2 Monkeypox Treatment Market Overview
6.3 Hospital Pharmacy
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size (2026-2035F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Hospital Pharmacy: Geographic Segmentation
6.4 Online Pharmacy
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size (2026-2035F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 Online Pharmacy: Geographic Segmentation
6.5 Retail Pharmacy
6.5.1 Introduction and Market Overview
6.5.2 Historic and Forecasted Market Size (2026-2035F)
6.5.3 Key Market Trends, Growth Factors and Opportunities
6.5.4 Retail Pharmacy: Geographic Segmentation
Chapter 7: Company Profiles and Competitive Analysis
7.1 Competitive Landscape
7.1.1 Competitive Positioning
7.1.2 Monkeypox Treatment Sales and Market Share By Players
7.1.3 Industry BCG Matrix
7.1.4 Heat Map Analysis
7.1.5 Monkeypox Treatment Industry Concentration Ratio (CR5 and HHI)
7.1.6 Top 5 Monkeypox Treatment Players Market Share
7.1.7 Mergers and Acquisitions
7.1.8 Business Strategies By Top Players
7.2 BAVARIAN NORDIC
7.2.1 Company Overview
7.2.2 Key Executives
7.2.3 Company Snapshot
7.2.4 Operating Business Segments
7.2.5 Product Portfolio
7.2.6 Business Performance
7.2.7 Key Strategic Moves and Recent Developments
7.2.8 SWOT Analysis
7.3 CHIMERIX
7.4 INC.
7.5 CIDIC COMPANY LIMITED
7.6 EMCURE PHARMACEUTICALS
7.7 EMERGENT
7.8 GILEAD SCIENCES INC.
7.9 HETERO DRUGS LIMITED
7.10 JINAN JINDA PHARMACEUTICAL CHEMISTRY CO. LTD.
7.11 MYLAN N.V.
7.12 OLON S.P.A.
7.13 PIRAMAL PHARMA SOLUTIONS
7.14 SIGA TECHNOLOGIES INC.
7.15 SONOFI SA
7.16 TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Chapter 8: Global Monkeypox Treatment Market Analysis, Insights and Forecast, 2026-2035
8.1 Market Overview
8.2 Historic and Forecasted Market Size By Type
8.2.1 Oral
8.2.2 Injectable
8.3 Historic and Forecasted Market Size By Application
8.3.1 Hospital Pharmacy
8.3.2 Online Pharmacy
8.3.3 Retail Pharmacy
Chapter 9: North America Monkeypox Treatment Market Analysis, Insights and Forecast, 2026-2035
9.1 Key Market Trends, Growth Factors and Opportunities
9.2 Impact of Covid-19
9.3 Key Players
9.4 Key Market Trends, Growth Factors and Opportunities
9.4 Historic and Forecasted Market Size By Type
9.4.1 Oral
9.4.2 Injectable
9.5 Historic and Forecasted Market Size By Application
9.5.1 Hospital Pharmacy
9.5.2 Online Pharmacy
9.5.3 Retail Pharmacy
9.6 Historic and Forecast Market Size by Country
9.6.1 US
9.6.2 Canada
9.6.3 Mexico
Chapter 10: Eastern Europe Monkeypox Treatment Market Analysis, Insights and Forecast, 2026-2035
10.1 Key Market Trends, Growth Factors and Opportunities
10.2 Impact of Covid-19
10.3 Key Players
10.4 Key Market Trends, Growth Factors and Opportunities
10.4 Historic and Forecasted Market Size By Type
10.4.1 Oral
10.4.2 Injectable
10.5 Historic and Forecasted Market Size By Application
10.5.1 Hospital Pharmacy
10.5.2 Online Pharmacy
10.5.3 Retail Pharmacy
10.6 Historic and Forecast Market Size by Country
10.6.1 Bulgaria
10.6.2 The Czech Republic
10.6.3 Hungary
10.6.4 Poland
10.6.5 Romania
10.6.6 Rest of Eastern Europe
Chapter 11: Western Europe Monkeypox Treatment Market Analysis, Insights and Forecast, 2026-2035
11.1 Key Market Trends, Growth Factors and Opportunities
11.2 Impact of Covid-19
11.3 Key Players
11.4 Key Market Trends, Growth Factors and Opportunities
11.4 Historic and Forecasted Market Size By Type
11.4.1 Oral
11.4.2 Injectable
11.5 Historic and Forecasted Market Size By Application
11.5.1 Hospital Pharmacy
11.5.2 Online Pharmacy
11.5.3 Retail Pharmacy
11.6 Historic and Forecast Market Size by Country
11.6.1 Germany
11.6.2 UK
11.6.3 France
11.6.4 Netherlands
11.6.5 Italy
11.6.6 Russia
11.6.7 Spain
11.6.8 Rest of Western Europe
Chapter 12: Asia Pacific Monkeypox Treatment Market Analysis, Insights and Forecast, 2026-2035
12.1 Key Market Trends, Growth Factors and Opportunities
12.2 Impact of Covid-19
12.3 Key Players
12.4 Key Market Trends, Growth Factors and Opportunities
12.4 Historic and Forecasted Market Size By Type
12.4.1 Oral
12.4.2 Injectable
12.5 Historic and Forecasted Market Size By Application
12.5.1 Hospital Pharmacy
12.5.2 Online Pharmacy
12.5.3 Retail Pharmacy
12.6 Historic and Forecast Market Size by Country
12.6.1 China
12.6.2 India
12.6.3 Japan
12.6.4 South Korea
12.6.5 Malaysia
12.6.6 Thailand
12.6.7 Vietnam
12.6.8 The Philippines
12.6.9 Australia
12.6.10 New Zealand
12.6.11 Rest of APAC
Chapter 13: Middle East & Africa Monkeypox Treatment Market Analysis, Insights and Forecast, 2026-2035
13.1 Key Market Trends, Growth Factors and Opportunities
13.2 Impact of Covid-19
13.3 Key Players
13.4 Key Market Trends, Growth Factors and Opportunities
13.4 Historic and Forecasted Market Size By Type
13.4.1 Oral
13.4.2 Injectable
13.5 Historic and Forecasted Market Size By Application
13.5.1 Hospital Pharmacy
13.5.2 Online Pharmacy
13.5.3 Retail Pharmacy
13.6 Historic and Forecast Market Size by Country
13.6.1 Turkey
13.6.2 Bahrain
13.6.3 Kuwait
13.6.4 Saudi Arabia
13.6.5 Qatar
13.6.6 UAE
13.6.7 Israel
13.6.8 South Africa
Chapter 14: South America Monkeypox Treatment Market Analysis, Insights and Forecast, 2026-2035
14.1 Key Market Trends, Growth Factors and Opportunities
14.2 Impact of Covid-19
14.3 Key Players
14.4 Key Market Trends, Growth Factors and Opportunities
14.4 Historic and Forecasted Market Size By Type
14.4.1 Oral
14.4.2 Injectable
14.5 Historic and Forecasted Market Size By Application
14.5.1 Hospital Pharmacy
14.5.2 Online Pharmacy
14.5.3 Retail Pharmacy
14.6 Historic and Forecast Market Size by Country
14.6.1 Brazil
14.6.2 Argentina
14.6.3 Rest of SA
Chapter 15 Investment Analysis
Chapter 16 Analyst Viewpoint and Conclusion
Monkeypox Treatment Scope:
|
Report Data
|
Monkeypox Treatment Market
|
|
Monkeypox Treatment Market Size in 2025
|
USD XX million
|
|
Monkeypox Treatment CAGR 2025 - 2032
|
XX%
|
|
Monkeypox Treatment Base Year
|
2024
|
|
Monkeypox Treatment Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Bavarian Nordic, Chimerix, Inc., CIDIC Company Limited, Emcure Pharmaceuticals, Emergent, Gilead Sciences Inc., Hetero Drugs Limited, Jinan Jinda Pharmaceutical Chemistry Co. Ltd., Mylan N.V., Olon S.p.A., Piramal Pharma Solutions, SIGA Technologies Inc., Sonofi SA, Teva Pharmaceutical Industries Limited.
|
|
Key Segments
|
By Type
Oral
Injectable
By Applications
Hospital Pharmacy
Online Pharmacy
Retail Pharmacy
|
